IDRC Offices

IDRC has multiple offices and clinics in Uganda, each contributing to various research projects and studies to improve community health. Here is a brief summary of some of these locations and their activities: 

Tororo Research Clinic 

• Established in 2007, with subsequent renovations in 2009. 
• Conducted 5 large cohort clinical trials, including studies on HIV, malaria, placental malaria, and pharmacokinetics. 
• Services include clinical research, malaria surveillance, laboratory testing (including microscopy and PCR for malaria detection), antibiotic resistance testing, and nutritional evaluations. 
• The site supports clinical studies in Busia with sample processing and storage facilities and hosts a research laboratory for malaria immunology and parasitology studies.

Mbarara Office

• Supports the Sustainable East African Research for Community Health (SEARCH) collaboration in Mbarara district. 
• Served numerous projects impacting over 10 million Ugandans in 22 districts across Southwest, Southcentral, and Western Uganda 
• Hosted over 15 community and clinical research projects, shaping the policy landscape for HIV, Tuberculosis, and Hypertension. 
• Actively working on large-scale projects such as SEARCH 2.0, OPAL INTEGRATED HIV/HTN, P4P, and COVID-19 SUP & VAX 
• Dedicated team of departments led by the Programs Manager overseeing project planning, budgeting, procurements, staffing, and reporting. 
• Solid multidisciplinary, cross-sectoral, collaborative network including researchers, partners, and study participants across various districts 

Masafu General Hospital 

• Site opened in September 2016 after indoor residual spraying reduced the malaria burden in the Tororo district. 
• Hosted the Birth Cohort 3 study focusing on adverse birth outcomes in HIV-negative pregnant mothers in Busia district. 
• Equipped with consultation rooms, laboratory, pharmacy, and dispensing room. 
• Currently hosting the DPSP study evaluating dihydroartemisinin-piperaquine plus sulfadoxine-pyrimethamine for preventing malaria in pregnant women. 
• Hosting the IMPACT study examining if preventing malaria in pregnancy reduces malaria in infancy
• Also hosting the MIC-DroP study evaluating if malaria chemoprevention enhances the development of immunity to malaria in children.